Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma

American Journal of Clinical Pathology

Volumn 110, Issue 5, 1998, Pages 582-589

  Tworek, Joseph A ^a   Singleton, Timothy P ^a   Schnitzer, Bertram ^a   Hsi, Eric D ^a   Ross, Charles W ^a,b  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

CD23; FMC7; Mantle cell lymphoma; Small lymphocytic lymphoma

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LEUKOSIALIN;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

EID: 0031755578     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.5.582     Document Type: Article

References (28)

1. Weisenburger DD, Duggan MJ, Perry DA, et al. Non-Hodgkin's lymphoma of mantle zone origin. Pathol Annu. 1991;26:139-158.
2. Ben-Ezra J. Small lymphocytic lymphoma. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, Md: Williams & Wilkins, 1992:611.
3. Catovsky D, Cherchi M, Brooks D, et al. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7. Blood. 1981;58:406-408.
4. Dorfman DM, Pinkus GS. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol. 1994;7:326-331.
5. Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol. 1996;105:451-457.
6. Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8:1640-1645.
7. Murray PG, Janmohamed RMI, Crocker J. CD23 expression in non-Hodgkin lymphoma: immunohistochemical demonstration using the antibody BU38 on paraffin sections. J Pathol. 1991;165:125-128.
8. Orazi A, Cattoretti G, Polli N, et al. Distinct morphophenorypic features of chronic B-cell leukemias identified with CD1c and CD23 antibodies. Eur J Haematol. 1991;47:28-35.
9. Oertel J, Kastner M, Bai AR, et al. Analysis of chronic lymphoid leukemias according to FAB. Leuk Res. 1992;16:919-927.
10. Salter DM, Krajewski AS, Cunningham S. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma. J Pathol. 1988;154:209-222.
11. Stein H, Lennert K, Feller AC, et al. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res. 1984;42:67-147.
12. Huh YO, Pugh WC, Kantarjian HM, et al. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody. Am J Clin Pathol. 1994;101:283-289.
13. Zukerberg LR, Medeiros JL, Ferry JA, et al. Diffuse low-grade B-cell lymphomas: four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol. 1993;100:373-385.
14. Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol. 1989;42:567-584.
15. Almasri NM, Duque RE, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol. 1992;40:259-263.
16. Witzig TE, Li C-Y, Tefferi A, et al. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphoid leukemia. Am J Clin Pathol. 1994;101:312-317.
17. Santamaria LF, Bheekha R, vanReijsen FC, et al. Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells. Hum Imunol. 1993;37:23-30.
18. Liu YJ, Mason DY, Johnson GD, et al. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol. 1991;21:1905-1910.
19. Schuurman HJ, van Baarlen J, Huppes W, et al. Immunophenotyping of non-Hodgkin's lymphoma. Am J Pathol. 1987;129:140-151.
20. Williamson JMS, Grigor I, Smith MEF, et al. Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas. J Pathol. 1986;150:51-59.
21. Kumar S, Green GA, Teruya-Feldstein J, et al. Use of CD23(BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. Mod Pathol. 1996;9:925-929.
22. Said JW, Stall PN, Shintaku P, et al. Leu-22. A preferential marker for T-lymphocytes in paraffin sections. Staining profile in T-and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative disorders and various neoplastic processes. Am J Clin Pathol. 1989;91:542-549.
23. Maddy AH, Sanderson A, Mackie MJ, et al. The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukemia. Immunol. 1989;68:346-352.
24. Tefferi A, Bartholmai BJ, Witzig TE, et al. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol. 1996;106:457-461.
25. Zola H. Human leukocyte markers defined by antibodies derived from somatic cell hybrids IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. J Immunol. 1981;26:1373.
26. Ben-Ezra JM, Kornstein MJ. Antibody NCL-CD5 fails to detect neoplastic CD5+ cells in paraffin sections. Am J Clin Pathol. 1996;106:370-373.
27. Hanson CA, Gribbin TE, Schnitzer B, et al. CD11c (Leu-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood. 1990;76:2360-2367.
28. Perry DA, Bast MA, Armitage JO, et al. Diffuse intermediate lymphocytic lymphoma: a clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Cancer. 1990;66:1995-2000.